Findings point toward one of first therapies for Lou Gehrig's disease
Friday, June 13, 2014 - 11:41
in Biology & Nature
Researchers have determined that a copper compound known for decades may form the basis for a therapy for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. In humans, prior to this, no therapy for ALS has ever been discovered that could extend lifespan more than a few additional months.